Exploring Enhanced Cell-Based Therapy for Ischemic Heart Disease and Heart Failure
- PMID: 35807122
- PMCID: PMC9267183
- DOI: 10.3390/jcm11133837
Exploring Enhanced Cell-Based Therapy for Ischemic Heart Disease and Heart Failure
Abstract
Ischemic heart disease (IHD) and heart failure (HF) remain the leading causes of death worldwide [...].
Conflict of interest statement
The author declares no conflict of interest.
References
-
- Madonna R., Guarnieri S., Kovácsházi C., Görbe A., Giricz Z., Geng Y., Mariggiò M.A., Ferdinandy P., De Caterina R. Telomerase/myocardin expressing mesenchymal cells induce survival and cardiovascular markers in cardiac stromal cells undergoing ischaemia/reperfusion. J. Cell. Mol. Med. 2021;25:5381–5390. doi: 10.1111/jcmm.16549. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous